Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
Lars Vedel Kessing, Helene C. W. Rytgaard, Claus Thorn Ekstrøm, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 3050-3060
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications
Zohreh Jafari, Ashkan Bigham, Sahar Sadeghi, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 1, pp. 2-36
Open Access | Times Cited: 56
Diabetes, antidiabetic medications and risk of depression – A population-based cohort and nested case-control study
Ida Kim Wium‐Andersen, Merete Osler, Martin Balslev Jørgensen, et al.
Psychoneuroendocrinology (2022) Vol. 140, pp. 105715-105715
Open Access | Times Cited: 49
Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders
Nuojin Li, Tian Zhou, Erkang Fei
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8281-8281
Open Access | Times Cited: 39
Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
Daniel Cooper, Ranuk Ramachandra, Felicia Ceban, et al.
Journal of Psychiatric Research (2023) Vol. 164, pp. 80-89
Closed Access | Times Cited: 33
Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression
Sixin Li, Dong Yang, Chao Zhou, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 25
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes
Huilin Tang, Ying Lü, William T. Donahoo, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 8, pp. 1004-1015
Closed Access | Times Cited: 9
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
Antihypertensive Drugs and Risk of Depression
Lars Vedel Kessing, Helene C. W. Rytgaard, Claus Thorn Ekstrøm, et al.
Hypertension (2020) Vol. 76, Iss. 4, pp. 1263-1279
Closed Access | Times Cited: 66
Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Jeffrey S. Gonzalez, Ionut Bebu, Heidi Krause‐Steinrauf, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 610-619
Open Access | Times Cited: 7
The interplay of gut microbiota, obesity, and depression: insights and interventions
Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Closed Access | Times Cited: 7
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
Rae J. Herman, Heath D. Schmidt
Physiology & Behavior (2024) Vol. 281, pp. 114565-114565
Open Access | Times Cited: 5
Prevalensi Problem Depresi pada Pasien Diabetes Mellitus di Puskesmas
Salma Fajar Puspita, Saepudin
Jurnal Ilmiah Farmasi (Scientific Journal of Pharmacy) (2025) Vol. 20, Iss. 2, pp. 194-206
Closed Access
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Curvilinear association between cardiometabolic index and depressive symptoms in individuals aged 45 and older: a cross-sectional study of CHARLS
Sibo Han, Yingqi Zhang, Bingxin Wu, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development
Guoqi Zhu, Shaojie Yang
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1479-1497
Open Access | Times Cited: 31
Elevated lipids are associated with reduced regional brain structure in youth with bipolar disorder
Kody G. Kennedy, Alvi H. Islam, Anahit Grigorian, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 143, Iss. 6, pp. 513-525
Closed Access | Times Cited: 27
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 32-43
Closed Access | Times Cited: 21
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
Yong-Mei Zhang, Hai-chao Zong, Yingbei Qi, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3955-3965
Open Access | Times Cited: 11
Visceral adipose tissue-derived extracellular vesicles promote stress susceptibility in obese mice via miR-140-5p
Hao Wang, Li Zhang, Wenying Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Metformin: Beyond Diabetes Management to Neuroprotection and Cognitive Enhancement
Priyanka Gupta, Sirshak Dutta, Rajiv Jash, et al.
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Depression in Older Adults With Type 2 Diabetes
Huilin Tang, Ying Lü, William T. Donahoo, et al.
Annals of Internal Medicine (2025)
Closed Access
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP‐1RA‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Metformin alleviates the depression-like behaviors of elderly apoE4 mice via improving glucose metabolism and mitochondrial biogenesis
Yingbin Lin, Xiaoman Dai, Jing Zhang, et al.
Behavioural Brain Research (2022) Vol. 423, pp. 113772-113772
Closed Access | Times Cited: 16
Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
Mengmeng Zhu, Yiwen Li, Binyu Luo, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Metabolic disorders induced by psychotropic drugs
André Scheen
Annales d Endocrinologie (2023) Vol. 84, Iss. 3, pp. 357-363
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top